DiaSorin S.p.A. (id:4882 DIA)
107.45 EUR
Opening hours: 09:00 - 05:30 (Central European Standard Time: 11/23/2024 11:51:34 AM)
Exchange closed, opens in 1 day 21 hours
About DiaSorin S.p.A.
Market Capitalization 5.82B
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.
| Headquarters (address) |
Via Crescentino Saluggia 13040 VC Italy |
| Phone | 39 01 614871 |
| Website | https://diasoringroup.com/en |
| Employees | 3,184 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Ticker | DIA |
| Exchange | Italian Stock Exchange |
| Currency | EUR |
| 52 week range | 82.72 - 112.35 |
| Market Capitalization | 5.82B |
| Dividend yield forward | 4.29 % |
| Dividend yield forward Italy (ID:74, base:166) | 13.85 % |
| P/E trailing | 31.41 |
| P/E forward | 26.06 |
| Price/Sale | 4.94 |
| Price/Book | 3.55 |
| Beta | 0.192 |
| EPS | 3.41 |
| EPS Italy (ID:74, base:207) | 0.781 |
Dividend growth streak
DiaSorin S.p.A. has raised their dividend 10.00 years in a row. This is above the 4.478450 year average in the 'Diagnostics & Research' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: DiaSorin S.p.A. has raised their dividend 4.29 years in a row. This is below the 41189.439400 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: DiaSorin S.p.A. has raised their dividend 5.01 years in a row. This is below the 24.013800 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: DiaSorin S.p.A. has raised their dividend 8.20 years in a row. This is below the 10.159600 year average in the 'Diagnostics & Research' industry
Payout Ratio
Payout Ratio: DiaSorin S.p.A. has raised their dividend 33.70 years in a row. This is below the 147.934300 year average in the 'Diagnostics & Research' industry
Dividend growth streak
DiaSorin S.p.A. has raised their dividend 10.00 years in a row. This is above the 4.478450 year average in the 'Diagnostics & Research' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: DiaSorin S.p.A. has raised their dividend 4.29 years in a row. This is below the 41189.439400 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: DiaSorin S.p.A. has raised their dividend 5.01 years in a row. This is below the 24.013800 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: DiaSorin S.p.A. has raised their dividend 8.20 years in a row. This is below the 10.159600 year average in the 'Diagnostics & Research' industry
Payout Ratio
Payout Ratio: DiaSorin S.p.A. has raised their dividend 33.70 years in a row. This is below the 147.934300 year average in the 'Diagnostics & Research' industry